Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for Pegaspargase (compound)


PubChem Substance
Name: pegaspargase
PubChem Substance ID: 3812654
Synonyms:
Pegaspargasa [INN-Spanish]; Asparaginase, reaction product with succinic anhydride, esters with polyethylene glycol, monomethyl ether; 130167-69-0; Oncaspar; Pegaspargasum [INN-Latin]; (Monomethoxypolyethylene glycol succinimidyl)74-L-asparaginase; Pegaspargase; Pegaspargase [USAN:INN]
DrugBank
Identification
Name: pegaspargase
Name (isomeric): DB00059
Drug Type: biotech
Synonyms:
Putative L-asparaginase precursor; L-asparagine amidohydrolase
Brand: Oncaspar (Enzon Inc)
Category: Antineoplastic Agents
CAS number: 130167-69-0
Pharmacology
Indication: For treatment of acute lymphoblastic leukemia
Pharmacology:
In a significant number of patients with acute leukemia, the malignant cells are dependent on an exogenous source of asparagine for survival. Normal cells, however, are able to synthesize asparagine and thus are affected less by the rapid depletion produced by treatment with the enzyme asparaginase. Oncaspar exploits a metabolic defect in asparagin...
show more »
Mechanism of Action: Pegaspargase, more effective than asparaginase, converts asparagine to aspartic acid and ammonia. It facilitates production of oxaloacetate which is needed for general cellular metabolism. Some malignant cells lose the ability to produce asparagine and so the loss of exogenous sources of asparagine leads to cell death.
Affected organisms: Humans and other mammals
Interactions
Drug interaction:
TrastuzumabTrastuzumab may increase the risk of neutropenia and anemia. Monitor closely for signs and symptoms of adverse events.

Targets